查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2134649

心臟外科生物補片市場：全球市場預測，2026-2032年

Cardiac Surgery Biopatch Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟外科生物補片市場將成長至 8.6152 億美元，複合年成長率為 8.55%。

主要市場統計數據
基準年 2025 4.8488億美元
預計年份：2026年 5.1965億美元
預測年份 2032 8.6152億美元
複合年成長率 (%) 8.55%

心臟外科生物補片：概述

心臟外科生物補片是一種可植入或用於手術部位的材料，旨在輔助組織修復、加強脆弱的解剖部位、控制出血或在心血管手術中提供保護性介面。其臨床價值取決於生物相容性、操作特性、滅菌相容性、組織整合以及與既定手術流程的契合度。其應用受手術量、醫院規程、外科醫生熟練程度、報銷條件、監管要求以及安全性和臨床療效證據的影響。

臨床和操作方面的改變將徹底改變我們使用生物補片進行心臟手術的方式。

目前，材料的選擇趨勢正朝著兼具可靠止血作用、機械支撐、易於應用以及可預測分解或與組織整合等特性的方向發展。在醫院中，感染預防、營運效率、採購流程標準化以及基於實證醫學的醫療設備選擇變得日益重要。微創心血管手術和復健促進方案的普及也推動了對能夠精準應用並最大限度減少組織損傷的產品的需求。對生物來源原料採購、生產一致性、可追溯性和上市後監測的監管力度不斷加強，使得品管系統和臨床文件記錄變得愈發重要。

人工智慧對生物斑塊生態系統的影響

人工智慧不會取代臨床判斷，但它可以為心臟外科生物補片的整個生態系統做出貢獻。影像和預測分析可以幫助識別出血、癒合不良或術後併發症高風險患者，從而支持制定更個人化的手術方案。機器學習工具還可以幫助最佳化庫存、管理手術室排班、檢測不利事件訊號並分析真實世界的臨床數據。然而，其應用需要檢驗的資料集、透明的效能評估、網路安全措施、隱私保護以及嚴格的監督，以防止演算法偏差和不恰當的產品選擇。

心臟外科生物補片引入的區域趨勢

北美地區的特點是擁有先進的心臟醫療基礎設施、完善的醫療設備監管體系，並高度重視臨床證據、醫院價值分析和術後結果。歐洲則將高度專業化的醫療保健與各國特有的採購和報銷環境結合，其中歐盟尤其強調合規性、文件記錄和安全要求。亞太地區的醫療保健體系多元化，既有日本、澳洲和韓國高度專業化的醫療中心，也有其他地區快速發展的醫療保健體系。本地化生產、培訓和價格合理性仍然是重要的考慮因素。拉丁美洲受到三級心臟醫療服務可近性、公共採購、進口要求和專業人才集中度等差異的影響。在中東，對先進醫院功能的投資正在不斷推進，其實施通常與轉診中心功能、臨床培訓和集中採購密切相關。非洲的情況仍然高度複雜，醫療服務的可近性與專業醫療人員的配備、基礎設施、捐助者支持計畫以及心臟外科中心的可近性密切相關。

東協、金磚國家、歐盟、七國集團、海灣合作理事會和北約的集團層級趨勢

東協成員國的心臟醫療保健體系、監管成熟度和對進口外科材料的依賴程度差異顯著，因此臨床醫生培訓和靈活的分銷模式至關重要。金磚國家擁有龐大且多元化的病患群體，以及不斷增強的國內醫療設備研發能力，但各國在採購、報銷和監管途徑方面存在顯著差異。歐盟受益於一體化的監管原則，同時在採購和臨床應用方面保持著國家間的差異。七國集團（G7）的醫療保健體系通常強調實證醫學、病人安全、醫療技術評估和供應韌性。海灣合作理事會（GCC）國家擁有眾多設備齊全的集中式轉診醫院，可透過集中採購和專家合作來採用先進技術。雖然北約成員國並非單一的醫療保健市場，但它們對醫療保健能力、供應連續性和互通性的通用關注可能會影響其關鍵外科產品的韌性計畫。

針對心臟外科生物補片的國家特定考慮因素

澳洲擁有專業的心臟中心、嚴格的品質標準以及地理分散的服務系統。巴西擁有豐富的臨床專業知識，但面臨區域差異和複雜的公私合作採購環境。加拿大在其分散的醫療保健體系中強調循證採購。中國在維持嚴格的註冊制度和醫院層級評估的同時，也正在擴大其國內醫療設備研發能力。法國、德國、義大利和西班牙均遵循歐洲法規結構，但在醫院採購、保險報銷和區域實施方面存在差異。印度擁有眾多公立和私立心臟護理機構，價格可負擔性、本地生產和專家診療是其採用醫療器材的關鍵因素。日本強調品質、可靠性以及與臨床實踐的密切結合。韓國將先進的醫院與高技能的醫療設備產業結合。墨西哥主要大都會區與其他地區在醫療服務取得上有差異。俄羅斯的情況受國內供應狀況、監管流程和專科醫療服務取得的影響。英國高度重視臨床證據、採購評估和醫療保健體系價值觀。美國的特點是擁有先進的心臟中心、完善的醫療設備監管體系，並對安全性、治療效果和醫院經濟效益進行嚴格審查。

心臟外科生物補片領域產業領導者的策略重點

產業領導者應優先考慮強力的臨床證據，這些證據應涵蓋出血控制、癒合、感染風險、操作以及相關患者亞群。產品開發應著重於直覺易用的應用、可靠的儲存和滅菌性能、可追溯性以及與心臟外科手術流程的兼容性。監管策略應根據各司法管轄區的具體情況量身定做，並儘早專注於生物材料、生產控制、標籤和上市後監測。銷售團隊不應僅依賴產品推廣，而應透過實務培訓和透明的價值文檔，為外科醫生、循環系統、護士和採購委員會提供支援。供應鏈韌性應包括認證供應商、緊急時應對計畫以及清晰的溫度和儲存控制。負責任地使用人工智慧必須輔以檢驗、管治、網路安全和人工監督。

心臟外科生物貼片調查方法執行摘要

本執行摘要採用結構化的定性審查框架，重點關注與心臟外科生物補片相關的臨床、監管、運作和地理因素。評估從手術適應症、材料性能、醫院採用標準、醫療保健系統背景和技術趨勢等角度系統化地整理證據。區域、群體和國家層面的觀點均來自公開可用的各類證據，包括監管要求、臨床實踐文獻、醫療保健系統文件、採購原則以及公開的心臟醫療保健基礎設施資訊。本摘要未使用任何市場估算、預測、市場規模、市場佔有率、預測結果或公司特定聲明。在做出任何營運決策之前，應根據現行的當地法規、臨床指南和醫療保健特定採購要求對解釋進行檢驗。

結論：生物貼片的引入安全且有實證依據

心臟外科生物補片融合了生物材料創新、手術效果、病人安全和醫院運作等多個面向。最有效的推廣途徑是將已證實的臨床效用與可靠的生產製造、清晰的監管文件、實用的培訓和穩定的供應相結合。北美、拉丁美洲、歐洲、中東和非洲、亞太地區，甚至特定經濟和政治集團以及各國的情況都存在顯著差異。那些能夠將本地推廣經驗與嚴謹的證據、負責任的數位化工具以及持續的上市後學習相結合的領導者，將更有能力支持安全有效的應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心臟外科生物補片市場：依產品類型分類

  • 浸漬型
    • 纖維蛋白
    • 長號
  • 非浸漬型

第 8 章：心臟外科生物補片市場：依補片材料分類。

  • 膠原蛋白
  • 明膠
  • 合成

第9章：心臟外科生物補片市場：依應用領域分類

  • 止血
  • 組織能力提升

第10章：心臟外科生物補片市場：依最終用途分類

  • 門診手術中心
  • 診所
  • 醫院

第11章：心臟外科生物補片市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：心臟外科生物補片市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：心臟外科生物補片市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Acelity LP Inc.
  • Axogen, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Collagen Matrix, Inc.
  • Cook Medical LLC
  • CryoLife, Inc.
  • DemeTECH Corporation, Inc.
  • Ethicon Inc.
  • Hemostasis LLC
  • Integra LifeSciences Holdings Corporation
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • MiMedx Group, Inc.
  • Organogenesis Inc.
  • Porvair plc
  • Smith & Nephew plc
  • Stryker Corporation
  • Surgical Innovations Group plc
  • Terumo Corporation
  • Tissue Science Laboratories Ltd
  • Zimmer Biomet Holdings, Inc.

第16章 主要專家

Product Code: MRR-F774F6337011

The Cardiac Surgery Biopatch Market is projected to grow by USD 861.52 million at a CAGR of 8.55% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 484.88 million
Estimated Year [2026] USD 519.65 million
Forecast Year [2032] USD 861.52 million
CAGR (%) 8.55%

Cardiac Surgery Biopatches: Executive Overview

Cardiac surgery biopatches are implantable or surgical-site materials designed to support tissue repair, reinforce vulnerable anatomical areas, manage bleeding, or provide a protective interface during cardiovascular procedures. Their clinical value depends on biocompatibility, handling characteristics, sterilization compatibility, tissue integration, and fit with established surgical workflows. Adoption is shaped by procedure volume, hospital protocols, surgeon familiarity, reimbursement conditions, regulatory requirements, and evidence concerning safety and clinical performance.

Clinical and Operational Shifts Reshaping Cardiac Surgery Biopatches

The landscape is shifting toward materials that combine reliable hemostasis, mechanical support, ease of application, and predictable degradation or integration. Hospitals are placing greater emphasis on infection prevention, operating-room efficiency, standardized procurement, and evidence-based device selection. Less invasive cardiac procedures and enhanced-recovery pathways are also encouraging products that can be applied precisely while minimizing additional tissue disruption. Regulatory scrutiny is increasing around biologic sourcing, manufacturing consistency, traceability, and post-market surveillance, making quality systems and clinical documentation increasingly important.

How Artificial Intelligence Is Influencing the Biopatch Ecosystem

Artificial intelligence can contribute across the cardiac surgery biopatch ecosystem without replacing clinical judgment. Imaging and predictive analytics may help identify patients at elevated risk of bleeding, impaired healing, or postoperative complications, supporting more tailored procedural planning. Machine-learning tools can also assist with inventory optimization, operating-room scheduling, adverse-event signal detection, and analysis of real-world clinical data. However, implementation requires validated datasets, transparent performance evaluation, cybersecurity controls, privacy safeguards, and careful oversight to prevent algorithmic bias or inappropriate product selection.

Regional Insights Across Cardiac Surgery Biopatch Adoption

North America is characterized by advanced cardiac-care infrastructure, established device oversight, and strong attention to clinical evidence, hospital value analysis, and postoperative outcomes. Europe combines sophisticated specialist care with country-specific procurement and reimbursement environments, while the European Union places particular emphasis on conformity, documentation, and safety requirements. Asia-Pacific presents diverse healthcare systems, ranging from highly specialized centers in Japan, Australia, and South Korea to rapidly developing capacity elsewhere; local manufacturing, training, and affordability remain important considerations. Latin America is influenced by uneven access to tertiary cardiac services, public procurement, import requirements, and concentration of specialist expertise. The Middle East is investing in advanced hospital capacity, with adoption often linked to referral-center capabilities, clinical training, and centralized purchasing. Africa remains highly heterogeneous, and availability is closely connected to specialist workforce capacity, infrastructure, donor-supported programs, and access to cardiac surgery centers.

Group-Level Dynamics Across ASEAN, BRICS, the EU, G7, GCC, and NATO

ASEAN members differ substantially in cardiac-care capacity, regulatory maturity, and dependence on imported surgical materials, making clinician education and adaptable distribution models important. BRICS economies combine large and diverse patient populations with growing domestic medical-device capabilities, but procurement, reimbursement, and regulatory pathways vary considerably. The European Union benefits from integrated regulatory principles while retaining national differences in purchasing and clinical implementation. G7 healthcare systems generally emphasize evidence, patient safety, health-technology assessment, and supply resilience. GCC countries often have concentrated, well-equipped referral hospitals and can adopt advanced technologies through centralized purchasing and specialist partnerships. NATO members do not constitute a single healthcare market, but shared attention to medical readiness, supply continuity, and interoperability can influence resilience planning for essential surgical products.

Country-Level Considerations for Cardiac Surgery Biopatches

Australia combines specialized cardiac centers with stringent quality expectations and geographically dispersed service delivery. Brazil has substantial clinical expertise but faces regional disparities and complex public-private procurement conditions. Canada emphasizes evidence-informed purchasing across a decentralized health system. China is expanding domestic medical-device capabilities while maintaining rigorous registration and hospital-level evaluation. France, Germany, Italy, and Spain operate within the European regulatory framework but differ in hospital procurement, reimbursement, and regional implementation. India has a broad spectrum of public and private cardiac-care providers, with affordability, local production, and specialist access central to adoption. Japan emphasizes quality, reliability, and careful clinical integration; South Korea combines advanced hospitals with a technologically capable device sector. Mexico faces variation in access between major urban centers and other regions. Russia's environment is influenced by domestic supply considerations, regulatory processes, and access to specialized care. The United Kingdom places strong weight on clinical evidence, procurement evaluation, and health-system value. The United States features sophisticated cardiac centers, formal device oversight, and intensive scrutiny of safety, outcomes, and hospital economics.

Strategic Priorities for Industry Leaders in Cardiac Surgery Biopatches

Industry leaders should prioritize robust clinical evidence that addresses bleeding control, healing, infection risk, handling, and relevant patient subgroups. Product development should focus on intuitive application, dependable storage and sterilization characteristics, traceability, and compatibility with cardiac surgical workflows. Regulatory strategies should be tailored to each jurisdiction, with early attention to biologic materials, manufacturing controls, labeling, and post-market monitoring. Commercial teams should support surgeons, perfusionists, nurses, and procurement committees with practical training and transparent value documentation rather than relying solely on product promotion. Supply-chain resilience should include qualified suppliers, contingency planning, and clear temperature or storage controls. Responsible use of artificial intelligence should be accompanied by validation, governance, cybersecurity, and human oversight.

Research Methodology for the Cardiac Surgery Biopatch Executive Summary

This executive summary uses a structured qualitative review framework focused on the clinical, regulatory, operational, and geographic factors relevant to cardiac surgery biopatches. The assessment organizes evidence around surgical applications, material performance, hospital adoption criteria, healthcare-system conditions, and technology trends. Regional, group, and country perspectives are synthesized from publicly available categories of evidence such as regulatory requirements, clinical-practice literature, health-system documentation, procurement principles, and published information on cardiac-care infrastructure. No market estimates, market sizing, market shares, forecasts, or company-specific claims are used. Interpretations should be validated against current local regulations, clinical guidelines, and institution-specific purchasing requirements before operational decisions are made.

Conclusion: Building Safe, Evidence-Based Biopatch Adoption

Cardiac surgery biopatches sit at the intersection of biomaterials innovation, surgical performance, patient safety, and hospital operations. The strongest adoption pathways will connect demonstrable clinical utility with dependable manufacturing, clear regulatory documentation, practical training, and resilient supply. Conditions differ widely across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, as well as across the specified economic and political groups and individual countries. Leaders that combine local implementation insight with rigorous evidence, responsible digital tools, and continuous post-market learning will be better positioned to support safe and effective use.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cardiac Surgery Biopatch Market, by Product Type

  • 7.1. Introduction
  • 7.2. Impregnated
    • 7.2.1. Fibrin
    • 7.2.2. Thrombin
  • 7.3. Non-Impregnated

8. Cardiac Surgery Biopatch Market, by Patch Material

  • 8.1. Introduction
  • 8.2. Collagen
  • 8.3. Gelatin
  • 8.4. Synthetic

9. Cardiac Surgery Biopatch Market, by Application

  • 9.1. Introduction
  • 9.2. Hemostasis
  • 9.3. Tissue Augmentation

10. Cardiac Surgery Biopatch Market, by End Use

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Clinics
  • 10.4. Hospitals

11. Cardiac Surgery Biopatch Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Cardiac Surgery Biopatch Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Cardiac Surgery Biopatch Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Acelity L.P. Inc.
  • 15.2. Axogen, Inc.
  • 15.3. B. Braun Melsungen AG
  • 15.4. Baxter International Inc.
  • 15.5. Collagen Matrix, Inc.
  • 15.6. Cook Medical LLC
  • 15.7. CryoLife, Inc.
  • 15.8. DemeTECH Corporation, Inc.
  • 15.9. Ethicon Inc.
  • 15.10. Hemostasis LLC
  • 15.11. Integra LifeSciences Holdings Corporation
  • 15.12. LeMaitre Vascular, Inc.
  • 15.13. Medtronic plc
  • 15.14. MiMedx Group, Inc.
  • 15.15. Organogenesis Inc.
  • 15.16. Porvair plc
  • 15.17. Smith & Nephew plc
  • 15.18. Stryker Corporation
  • 15.19. Surgical Innovations Group plc
  • 15.20. Terumo Corporation
  • 15.21. Tissue Science Laboratories Ltd
  • 15.22. Zimmer Biomet Holdings, Inc.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Cardiac Surgery Biopatch Market, Years Considered for the Study
  • FIGURE 2. Global Cardiac Surgery Biopatch Market, Research Design
  • FIGURE 3. Global Cardiac Surgery Biopatch Market, Research Framework
  • FIGURE 4. Global Cardiac Surgery Biopatch Market, Data Triangulation
  • FIGURE 5. Global Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Cardiac Surgery Biopatch Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Cardiac Surgery Biopatch Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Cardiac Surgery Biopatch Market Size, by Patch Material, 2025 vs 2032 (%)
  • FIGURE 9. Global Cardiac Surgery Biopatch Market Size, by Patch Material, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Cardiac Surgery Biopatch Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Cardiac Surgery Biopatch Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Cardiac Surgery Biopatch Market Size, by End Use, 2025 vs 2032 (%)
  • FIGURE 13. Global Cardiac Surgery Biopatch Market Size, by End Use, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Cardiac Surgery Biopatch Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Cardiac Surgery Biopatch Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Cardiac Surgery Biopatch Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Cardiac Surgery Biopatch Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Cardiac Surgery Biopatch Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Cardiac Surgery Biopatch Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Cardiac Surgery Biopatch Market Segmentation & Coverage
  • TABLE 2. Global Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Impregnated Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Impregnated Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Impregnated Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Fibrin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Fibrin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Fibrin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Thrombin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Thrombin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Thrombin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Non-Impregnated Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Non-Impregnated Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Non-Impregnated Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 17. Global Collagen Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Collagen Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Collagen Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Gelatin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Gelatin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Gelatin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Synthetic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Synthetic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Synthetic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 27. Global Hemostasis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 28. Global Hemostasis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 29. Global Hemostasis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 30. Global Tissue Augmentation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Tissue Augmentation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Tissue Augmentation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 34. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Cardiac Surgery Biopatch Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Asia-Pacific Cardiac Surgery Biopatch Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Asia-Pacific Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 46. Asia-Pacific Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 47. Asia-Pacific Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 48. Asia-Pacific Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 49. Asia-Pacific Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 50. North America Cardiac Surgery Biopatch Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. North America Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 52. North America Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 53. North America Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 54. North America Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 55. North America Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 56. Latin America Cardiac Surgery Biopatch Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Latin America Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 58. Latin America Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 59. Latin America Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 60. Latin America Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 61. Latin America Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 62. Europe Cardiac Surgery Biopatch Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Europe Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 64. Europe Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 65. Europe Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 66. Europe Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 67. Europe Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 68. Middle East Cardiac Surgery Biopatch Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Middle East Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 70. Middle East Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 71. Middle East Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 72. Middle East Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 73. Middle East Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 74. Africa Cardiac Surgery Biopatch Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Africa Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 76. Africa Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 77. Africa Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 78. Africa Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 79. Africa Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 80. Global Cardiac Surgery Biopatch Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 81. ASEAN Cardiac Surgery Biopatch Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. ASEAN Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 83. ASEAN Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 84. ASEAN Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 85. ASEAN Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 86. ASEAN Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 87. GCC Cardiac Surgery Biopatch Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. GCC Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 89. GCC Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 90. GCC Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 91. GCC Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 92. GCC Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 93. European Union Cardiac Surgery Biopatch Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. European Union Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 95. European Union Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 96. European Union Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 97. European Union Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 98. European Union Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 99. BRICS Cardiac Surgery Biopatch Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. BRICS Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 101. BRICS Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 102. BRICS Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 103. BRICS Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 104. BRICS Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 105. G7 Cardiac Surgery Biopatch Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. G7 Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 107. G7 Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 108. G7 Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 109. G7 Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 110. G7 Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 111. NATO Cardiac Surgery Biopatch Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 112. NATO Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 113. NATO Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 114. NATO Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 115. NATO Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 116. NATO Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 117. Global Cardiac Surgery Biopatch Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 118. United States Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 119. United States Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 120. United States Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 121. United States Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 122. United States Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 123. United States Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 124. Canada Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 125. Canada Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 126. Canada Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 127. Canada Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 128. Canada Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 129. Canada Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 130. Mexico Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 131. Mexico Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 132. Mexico Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 133. Mexico Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 134. Mexico Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 135. Mexico Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 136. Brazil Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 137. Brazil Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 138. Brazil Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 139. Brazil Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 140. Brazil Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 141. Brazil Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 142. United Kingdom Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 143. United Kingdom Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 144. United Kingdom Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 145. United Kingdom Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 146. United Kingdom Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 147. United Kingdom Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 148. Germany Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 149. Germany Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 150. Germany Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 151. Germany Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 152. Germany Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 153. Germany Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 154. France Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 155. France Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 156. France Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 157. France Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 158. France Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 159. France Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 160. Russia Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 161. Russia Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 162. Russia Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 163. Russia Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 164. Russia Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 165. Russia Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 166. Italy Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 167. Italy Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 168. Italy Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 169. Italy Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 170. Italy Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 171. Italy Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 172. Spain Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 173. Spain Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 174. Spain Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 175. Spain Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 176. Spain Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 177. Spain Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 178. China Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 179. China Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 180. China Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 181. China Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 182. China Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 183. China Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 184. India Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 185. India Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 186. India Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 187. India Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 188. India Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 189. India Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 190. Japan Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 191. Japan Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 192. Japan Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 193. Japan Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 194. Japan Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 195. Japan Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 196. Australia Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 197. Australia Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 198. Australia Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 199. Australia Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 200. Australia Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 201. Australia Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 202. South Korea Cardiac Surgery Biopatch Market Size, 2017-2032 (USD Million)
  • TABLE 203. South Korea Cardiac Surgery Biopatch Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 204. South Korea Cardiac Surgery Biopatch Market Size, by Impregnated, 2017-2032 (USD Million)
  • TABLE 205. South Korea Cardiac Surgery Biopatch Market Size, by Patch Material, 2017-2032 (USD Million)
  • TABLE 206. South Korea Cardiac Surgery Biopatch Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 207. South Korea Cardiac Surgery Biopatch Market Size, by End Use, 2017-2032 (USD Million)
  • TABLE 208. Global Cardiac Surgery Biopatch Market Share, by Key Player, 2025
  • TABLE 209. Global Cardiac Surgery Biopatch Market, Key Experts